CoChat
Sign Up
Cited by 94

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Brain‐Penetration and Neuron‐Targeting DNA Nanoflowers Co‐Delivering miR‐124 and Rutin for Synergistic Therapy of Alzheimer's Disease

Ouyang, Qin, Liu, Kai, Zhu, Qubo, Deng, Huiyin, Le, Yuan, Ouyang, Wen, Yan, Xiaoxin, Zhou, Wenhu, Tong, Jianbin·2022·Small
DOI 10.1002/smll.202107534
Open this paper in CoChat — free account

Abstract

Alzheimer disease (AD) is the leading cause of dementia that affects millions of old people. Despite significant advances in the understanding of AD pathobiology, no disease modifying treatment is available. MicroRNA‐124 (miR‐124) is the most abundant miRNA in the normal brain with great potency to ameliorate AD‐like pathology, while it is deficient in AD brain. Herein, the authors develop a DNA nanoflowers (DFs)‐based delivery system to realize exogenous supplementation of miR‐124 for AD therapy. The DFs with well‐controlled size and morphology are prepared, and a miR‐124 chimera is attached via hybridization. The DFs are further modified with RVG29 peptide to simultaneously realize brain‐blood barrier (BBB) penetration and neuron targeting. Meanwhile, Rutin, a small molecular ancillary drug, is co‐loaded into the DFs structure via its intercalation into the double stranded DNA region. Interestingly, Rutin could synergize miR‐124 to suppress the expression of both BACE1 and APP, thus achieving a robust inhibition of amyloid β generation. The nanosystem could pro‐long miR‐124 circulation in vivo, promote its BBB penetration and neuron targeting, resulting in a significant increase of miR‐124 in the hippocampus of APP/PS1 mice and robust therapeutic efficacy in vivo. Such a bio‐derived therapeutic system shows promise as a biocompatible nanomedicine for AD therapy.

Overview

Integrity signals

Registry

Crossref · 10.1002/smll.202107534

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 16 references

Research works printed but not linked: 67

  1. 10.1038/nrneurol.2017.111 · DOI · Paper page
  2. 10.1186/s13041-015-0163-5 · DOI
  3. 10.1371/journal.pone.0151397 · DOI
  4. 10.1021/acs.accounts.1c00055 · DOI
  5. 10.1038/s41582-018-0116-6 · DOI · Paper page
  6. 10.1016/j.trci.2017.10.005 · DOI
  7. 10.1038/nsmb.1552 · DOI
  8. 10.1016/j.siny.2012.07.008 · DOI
  9. 10.1007/s12035-017-0808-8 · DOI
  10. 10.3233/JAD-181053 · DOI · Paper page
  11. 10.1007/s12035-016-9845-y · DOI
  12. 10.18632/oncotarget.23119 · DOI · Paper page
  13. 10.1007/s11010-013-1800-x · DOI
  14. Yu B., 2018, Mol. Med. Rep., 17, 6736
  15. 10.1016/j.biopsych.2017.07.023 · DOI
  16. 10.1007/s11010-018-3367-z · DOI
  17. 10.1126/science.1163728 · DOI
  18. 10.1016/j.jconrel.2019.10.007 · DOI
  19. 10.1016/j.ijpharm.2019.118449 · DOI
  20. 10.1080/10717544.2020.1760960 · DOI
  21. 10.3390/molecules25081929 · DOI
  22. 10.1016/S0079-6123(09)17903-7 · DOI
  23. 10.1038/nprot.2015.078 · DOI
  24. 10.1021/acsami.5b06987 · DOI
  25. 10.1016/j.biomaterials.2020.120221 · DOI
  26. 10.1002/smll.202104722 · DOI
  27. 10.1016/j.biomaterials.2020.120591 · DOI
  28. 10.1038/nmat3253 · DOI
  29. 10.1021/acsami.9b18282 · DOI
  30. Iaboni M., 2016, Mol. Med. Rep., 5
  31. 10.3892/mmr.2020.11253 · DOI
  32. 10.1016/j.bbr.2014.02.002 · DOI
  33. 10.1021/ja406115e · DOI
  34. 10.1007/s11095-012-0958-3 · DOI
  35. 10.1038/s41557-018-0209-2 · DOI
  36. 10.1038/npp.2017.167 · DOI
  37. 10.1002/adma.202006483 · DOI
  38. 10.1002/anie.202002312 · DOI
  39. 10.1007/s00216-016-9313-6 · DOI
  40. 10.1016/j.biomaterials.2015.11.060 · DOI
  41. 10.1016/j.bioactmat.2020.08.017 · DOI
  42. 10.1039/D0RA07161G · DOI
  43. 10.1016/j.mattod.2020.02.001 · DOI
  44. 10.1038/sj.bjp.0704508 · DOI
  45. Chalatsa I., 2019, Front. Neurosci., 13
  46. 10.1001/jamaneurol.2013.5847 · DOI
  47. 10.1016/j.phymed.2016.07.007 · DOI
  48. 10.1016/j.toxlet.2017.08.082 · DOI
  49. 10.1016/j.biopha.2018.12.074 · DOI · Paper page
  50. 10.1007/s10571-014-0073-6 · DOI
  51. 10.1021/acs.chemrev.7b00161 · DOI
  52. 10.1186/s12951-020-00766-4 · DOI
  53. 10.1007/s10456-017-9568-3 · DOI
  54. 10.1016/j.biomaterials.2021.121065 · DOI
  55. 10.1523/JNEUROSCI.1521-05.2005 · DOI · Paper page
  56. 10.3233/JAD-2011-101629 · DOI
  57. 10.1016/j.neuro.2012.03.003 · DOI
  58. 10.1126/sciadv.aau6328 · DOI
  59. 10.1038/cr.2013.116 · DOI · Paper page
  60. 10.1007/s11064-019-02931-0 · DOI
  61. 10.1038/s41392-019-0061-x · DOI · Paper page
  62. 10.1186/s12974-021-02182-3 · DOI
  63. 10.1007/s10565-007-9017-y · DOI
  64. 10.1016/j.biomaterials.2011.02.006 · DOI
  65. 10.1016/j.bios.2019.111788 · DOI
  66. 10.1016/j.jconrel.2017.03.390 · DOI
  67. 10.1186/s40478-019-0865-5 · DOI

Cited by

Sorted by citations

See all 94

Metadata

Authors
Ouyang, Q., Liu, K., Zhu, Q., Deng, H., Le, Y., Ouyang, W., Yan, X., Zhou, W., & Tong, J.
Affiliations
  • Hunan Province Key Laboratory of Brain Homeostasis Third Xiangya Hospital Central South University Changsha Hunan 410013 P. R. China
  • Xiangya School of Pharmaceutical Sciences Central South University Changsha Hunan 410013 China
  • Department of Anesthesiology Third Xiangya Hospital Central South University Changsha Hunan 410013 P. R. China
  • Department of Anatomy and Neurobiology Central South University Xiangya School of Medicine Changsha Hunan 410013 China
ORCID
Venue
Small
Publisher
Wiley
Published
2022-02-19
Volume
18
Issue
14
ISSN
  • 1613-6810
  • 1613-6829
DOI
10.1002/smll.202107534
Cited by
94
References
16
Language
en
Licence
onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Funders
National Natural Science Foundation of China (81870861, 81471107, 21804144, U1903125, 82073799)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Brain‐Penetration and Neuron‐Targeting DNA Nanoflowers Co‐Delivering miR‐124 and Rutin for Synergistic Therapy of Alzheimer's Disease. https://app.cochat.ai/papers/10.1002/smll.202107534
The paper
Ouyang, Q., Liu, K., Zhu, Q., Deng, H., Le, Y., Ouyang, W., Yan, X., Zhou, W., & Tong, J. (2022). Brain‐Penetration and Neuron‐Targeting DNA Nanoflowers Co‐Delivering miR‐124 and Rutin for Synergistic Therapy of Alzheimer's Disease. Small. https://doi.org/10.1002/smll.202107534